Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
02/07/2008 | US20080032970 Amide Derivatives of 7-Amino-3-Phenyl-Dihydropyrimido[4,5-D]Pyrimidinones, Their Manufacture and Use as Pharmaceutical Agents |
02/07/2008 | US20080032969 Novel compounds |
02/07/2008 | US20080032966 Small Molecule Inhibitors of Mrp1 and Other Multidrug Transporters |
02/07/2008 | US20080032961 Therapy employing LXRalpha modolators |
02/07/2008 | US20080032953 Method For Inhibiting Prebiotic Effect Of Food Proteins |
02/07/2008 | US20080032947 Pka ligands and polynucleotides encoding pka ligands |
02/07/2008 | US20080032944 Target Nucleic Acid Of Retrovirus Integration |
02/07/2008 | US20080032934 Compositions for prevention of adhesions and other barrier applications |
02/07/2008 | US20080032931 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules |
02/07/2008 | US20080032924 Antifungal Peptides |
02/07/2008 | US20080032922 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression |
02/07/2008 | US20080032921 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions |
02/07/2008 | US20080032384 Pharmaceutical Preparation Containing Bacterial Cell Wall Skeleton |
02/07/2008 | US20080032320 Method of Screening Compound Capable of Accelerating or Inhibiting Apoptosis, Apoptosis Accelarator and Apoptosis Inhibitor |
02/07/2008 | US20080032279 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
02/07/2008 | US20080031977 Pharmaceutical compositions comprising cannabigerol |
02/07/2008 | US20080031971 Use Of Xenon For The Prevention Of Programmed Cell Death |
02/07/2008 | US20080031967 Compositions, products and methods for controlling weight in a mammal |
02/07/2008 | US20080031962 Microencapsulation of Cells in Hydrogels Using Electrostatic Potentials |
02/07/2008 | US20080031956 Bioimplant formulation |
02/07/2008 | US20080031954 Modulation of angiogenesis by a-beta peptide fragments |
02/07/2008 | US20080031942 Solid Preparation |
02/07/2008 | US20080031939 Process for the preparation of armodafinil |
02/07/2008 | US20080031936 Immunostimulatory nucleic acid molecules |
02/07/2008 | US20080031926 Administering to birds and snimals in need of contraception an nicarbazin and a carrier; inhibition of zona pellucida protein C (ZPC), measuring ZPC, and stopping administration to reversibly restore ZPC; added to feed; nontoxic; efficiency |
02/07/2008 | US20080031922 comprising a core and a membrane encasing it; for controlling the initial burst of therapeutically active agent from a delivery system that consists of at least one elastomer; an implant, intravaginal, intracervical or intrauterine device or transdermal patch |
02/07/2008 | US20080031919 Vasoocclusive microcoil including a radiopaque metal wire, the outer surface of which has pores with complex shapes containing a plastic agent that acts to accelerate healing once the coil is in place |
02/07/2008 | US20080031913 Method for manufacturing biomedical filler material rich-contained with growth factor |
02/07/2008 | US20080031912 Method for controlling cell migration on a surface |
02/07/2008 | US20080031901 Sustained release monoeximic formulations of opioid and nonopioid analgesics |
02/07/2008 | US20080031899 Nanoparticles for immunotherapy |
02/07/2008 | US20080031886 Viruses for the treatment of cellular proliferative disorders |
02/07/2008 | US20080031883 Condition-dependent, multiple target delivery system |
02/07/2008 | US20080031880 Use of ErbB receptor ligands in treating diabetes |
02/07/2008 | US20080031879 Wound healing agents; antiscarring; regeneration: antifibrotic agents: treatment of keloids or hypertrophic scars |
02/07/2008 | US20080031874 Treatment of endotoxemia using endotoxin neutralizing agents |
02/07/2008 | US20080031867 Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
02/07/2008 | US20080031862 Mitochondria-targeted antioxidants |
02/07/2008 | US20080031858 Cell-matrix microspheres, methods for preparation and applications |
02/07/2008 | US20080031855 Anticancer Agent Containing Minus-Strand Rna Virus |
02/07/2008 | US20080031850 Tissue Regeneration Method |
02/07/2008 | US20080031831 Oral anti-calculus compositions and methods of use thereof |
02/07/2008 | US20080031830 Dental Composition Containing an Epoxy Functional Carbosilane Compound |
02/07/2008 | US20080031819 Compositions and Methods that Enhance Articular Cartilage Repair |
02/07/2008 | US20080031816 Methods and compositions for identifying biomarkers |
02/07/2008 | US20080031813 Targeted Combination Immunotherapy of Cancer and Infectious Diseases |
02/07/2008 | US20080029083 Ejection liquid and ejection method |
02/07/2008 | CA2659835A1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |
02/07/2008 | CA2659687A1 Aqueous liquid preparation containing amide compound |
02/07/2008 | CA2652220A1 Adhesive preparation comprising methyl salicylate for percutaneous absorption |
02/07/2008 | CA2649044A1 Benzylphenyl glucopyranoside derivative |
02/06/2008 | EP1884524A2 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
02/06/2008 | EP1884247A2 Gastrin compositions and formulations, and methods of use and preparation |
02/06/2008 | EP1884235A1 Myeloerythroid progenitor differentiation inducer |
02/06/2008 | EP1883406A2 Compositions and methods for the sustained release of beta-alanine |
02/06/2008 | EP1324980B1 Citrullimycines, a process for their production and their use as pharmaceuticals |
02/06/2008 | EP1309596B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
02/06/2008 | EP0773939B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
02/06/2008 | CN101120006A Proteasome inhibitors and methods of using the same |
02/06/2008 | CN101119991A Salt of proline derivative, solvate thereof, and production method thereof |
02/06/2008 | CN101117330A Tartrate of isofagomine and use thereof |
02/06/2008 | CN101116741A Chinese traditional treatment medicine for treating yang-insufficiency type dysphagia |
02/06/2008 | CN101116727A Yang-establishing yin-nourishing ointment |
02/06/2008 | CN101116666A Compositions of estrogen-cyclodextrin complexes |
02/06/2008 | CN100366620C Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine) |
02/06/2008 | CN100366614C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
02/06/2008 | CN100366293C Inhibitors of complement activation |
02/06/2008 | CN100366287C Composition for the prevention and treatment of cellulitis |
02/06/2008 | CN100366254C Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases |
02/06/2008 | CN100366248C Skin care composition for mediating cell to cell communication |
02/06/2008 | CN100366244C Local used composition containing antifungal agent |
02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
02/05/2008 | US7326794 Process for the preparation of high purity perindopril and intermediates useful in the synthesis |
02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
02/05/2008 | US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide |
02/05/2008 | US7326731 Muscarinic agonists |
02/05/2008 | US7326727 Furanthiazole derivatives as heparanase inhibitors |
02/05/2008 | US7326722 N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation and their application in therapy |
02/05/2008 | US7326709 e.g. 1-((3-Phenyl-1,2,4-triazolo(3,4-a)phthalazines-6-yl)carbonyl)piperidine; high affinity to the benzodiazepine site of GABAA receptors; central nervous system (CNS) diseases such as depression, anxiety, and attention deficit disorder |
02/05/2008 | US7326707 Bicyclic melanocortin-specific compounds |
02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
02/05/2008 | US7326699 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives |
02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
02/05/2008 | US7326680 Administering adrenomedullin for inhibiting abnormal bradykinin-induced myometrial contraction |
02/05/2008 | US7326569 Hybridoma cell lines producing chimeric antibody having the variable regions of the antibody produced by a cell line with ATCC (TM) deposit number HB11364, HB11637, or HB11363 |
02/05/2008 | US7326537 In human blood, urine, saliva, tissue biopsy or autopsy material; immunoassay using a mono- or polyclonal antibody; detecting overexpression; diagnosis |
02/05/2008 | US7326427 Tablet composition containing Kampo medicinal extract and its manufacturing process |
02/05/2008 | US7326425 Biologically active compound hydrogen bonded to a first polyester containing tyrosine-derived diphenol units blended with a second polymer that degrades to promote the release of the active compound |
02/05/2008 | US7326418 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
02/05/2008 | US7326415 derived from epithelial cells and malignant lymphoma; also for irritable bowel syndrome, viral and other infections; genetic engineering; kits |
02/05/2008 | US7326411 Use of amino-terminally truncated RANTES to inhibit HIV viral replication |
02/05/2008 | US7325355 Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline |
02/05/2008 | CA2417635C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
02/05/2008 | CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
02/05/2008 | CA2383315C New derivatives of pyrimidin-4-ones, the process for the preparation thereof and the pharmaceutical compounds that contain them |
02/05/2008 | CA2349227C Substituted 2-phenylbenzimidazoles, the production thereof and their use |
02/05/2008 | CA2315703C Tripeptidyl peptidase inhibitors |
02/05/2008 | CA2315685C Molecular dispersion composition with enhanced bioavailability |
02/05/2008 | CA2289206C Efficient enantioselective addition reaction using an organozinc reagent |